Eli Lilly & Company Foundation logo

Eli Lilly & Company Foundation

North America, Indiana, United States, Indianapolis

Description

Eli Lilly & Company Foundation is an organization that supports programs designed to improve patient outcomes and enhance quality of life.

Investor Profile

Eli Lilly & Company Foundation has made 24 investments, with 6 in the past 12 months and 17% as lead.

Stage Focus

  • Series A (42%)
  • Series B (13%)
  • Series C (13%)
  • Seed (8%)
  • Grant (8%)
  • Series D (4%)
  • Convertible Note (4%)
  • Post Ipo Equity (4%)
  • Series Unknown (4%)

Country Focus

  • United States (92%)
  • United Kingdom (4%)
  • The Netherlands (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Biopharma
  • Pharmaceutical
  • Life Science
  • Manufacturing
  • Bioinformatics
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Eli Lilly & Company Foundation frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 3
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 6
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 4
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 3
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 6
Ono Venture Investment
North America, California, United States, San Francisco
Co-Investments: 3
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 3
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 4
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 4

Which angels does Eli Lilly & Company Foundation often collaborate with?

BT
North America, Massachusetts, United States, Marblehead
Shared Deals: 1
JS
North America, Quebec, Canada, Montréal
Shared Deals: 1

What are some of recent deals done by Eli Lilly & Company Foundation?

TRex Bio

South San Francisco, California, United States

TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.

BioinformaticsBiopharmaBiotechnology
Series BNov 13, 2024
Amount Raised: $84,000,000
Arda Therapeutics

San Francisco, California, United States

Arda is taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions.

BiotechnologyHealth CareTherapeutics
Series AOct 1, 2024
Amount Raised: $43,000,000
Elektrofi

Boston, Massachusetts, United States

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

Alternative MedicineBiotechnologyTherapeutics
Series CAug 22, 2024
Amount Raised: $112,250,000
Ionetix

San Francisco, California, United States

Ionetix is a pioneering end-to-end radiopharmaceutical provider for cardiac PET imaging.

BiotechnologyHealth CareManufacturingPharmaceutical
Series UnknownAug 7, 2024
Artax Biopharma

Cambridge, Massachusetts, United States

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

BiopharmaBiotechnologyHealth CareTherapeutics
Convertible NoteAug 6, 2024
Amount Raised: $8,000,000
Ajax Therapeutics

Cambridge, Massachusetts, United States

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.

BiotechnologyLife ScienceMedical
Series CMay 13, 2024
Amount Raised: $95,000,000
Capstan Therapeutics

San Diego, California, United States

Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.

BiotechnologyHealth CareTherapeutics
Series BMar 20, 2024
Amount Raised: $175,000,000
Zephyr AI

Fairfax Station, Virginia, United States

Zephyr AI is a healthcare technology company that reshapes traditional approaches to drug discovery and precision medicine.

Artificial Intelligence (AI)BiotechnologyMedical
Series AMar 13, 2024
Amount Raised: $111,000,000
Trans Solutions Research and Resource Center

Indianapolis, Indiana, United States

Trans Solutions Research and Resource Center empowers transgender and gender communities.

CommunitiesService Industry
GrantJun 27, 2023
Amount Raised: $500,000
Mediar Therapeutics

Cambridge, Massachusetts, United States

Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.

BiotechnologyHealth CareMedicalTherapeutics
Series AMar 15, 2023
Amount Raised: $85,000,000